Risk in treatment arm minus risk in control arm.
Including only studies with a placebo or other non-biphosphonate control.
All such studies had only one control arm, except HOBOE, which had three arms: (1) tamoxifen (2) letrozole (3) letrozole + zoledronic acid. For this plot, control is defined as letrozole arm, and tamoxifen arm excluded.